UY31699A1 - Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea - Google Patents

Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea

Info

Publication number
UY31699A1
UY31699A1 UY31699A UY31699A UY31699A1 UY 31699 A1 UY31699 A1 UY 31699A1 UY 31699 A UY31699 A UY 31699A UY 31699 A UY31699 A UY 31699A UY 31699 A1 UY31699 A1 UY 31699A1
Authority
UY
Uruguay
Prior art keywords
low viscosity
injection
triamcinolone acetonide
intravitrea
floculation
Prior art date
Application number
UY31699A
Other languages
English (en)
Spanish (es)
Inventor
Ruma Sarakar
Bhagwati Kabra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31699A1 publication Critical patent/UY31699A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
UY31699A 2008-03-11 2009-03-10 Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea UY31699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3545908P 2008-03-11 2008-03-11

Publications (1)

Publication Number Publication Date
UY31699A1 true UY31699A1 (es) 2009-05-29

Family

ID=40548758

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31699A UY31699A1 (es) 2008-03-11 2009-03-10 Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea

Country Status (21)

Country Link
US (3) US8128960B2 (https=)
EP (1) EP2262506B1 (https=)
JP (1) JP5581227B2 (https=)
KR (1) KR101555293B1 (https=)
CN (1) CN101959519B (https=)
AR (1) AR070824A1 (https=)
AU (1) AU2009223649B2 (https=)
BR (1) BRPI0909630B8 (https=)
CA (1) CA2717605C (https=)
CL (1) CL2009000573A1 (https=)
DK (1) DK2262506T3 (https=)
ES (1) ES2471122T3 (https=)
MX (1) MX2010009974A (https=)
PL (1) PL2262506T3 (https=)
PT (1) PT2262506E (https=)
RU (1) RU2481842C2 (https=)
SI (1) SI2262506T1 (https=)
TW (1) TWI468165B (https=)
UY (1) UY31699A1 (https=)
WO (1) WO2009114521A1 (https=)
ZA (1) ZA201005839B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5581227B2 (ja) * 2008-03-11 2014-08-27 アルコン リサーチ， リミテッド 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤
AU2009330517A1 (en) * 2008-12-22 2010-07-01 Alcon Research, Ltd. Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
CN102008488B (zh) * 2010-11-24 2012-10-10 广州固志医药科技有限公司 一种曲安奈德眼用制剂及其制备方法
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
MX373894B (es) * 2012-11-08 2020-07-09 Clearside Biomedical Inc Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
BR112015027762A2 (pt) 2013-05-03 2017-08-29 Clearside Biomedical Inc Aparelho e métodos para injeção ocular
WO2014197317A1 (en) 2013-06-03 2014-12-11 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
EP3157598A4 (en) 2014-06-20 2018-05-16 Clearside Biomedical, Inc. Variable diameter cannula and methods for controlling insertion depth for medicament delivery
US9694145B1 (en) 2016-03-29 2017-07-04 Joseph Onorato Auto-injector systems and method for delivering cyst medication on demand
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
IL305537B2 (en) 2016-08-12 2025-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a needle for administering a drug
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
AU2019207515B2 (en) * 2018-01-10 2024-11-14 Eye Co Pty Ltd Medical device and pharmaceutical composition for treatment of an eye disease or condition
USD893715S1 (en) 2018-11-06 2020-08-18 Joseph Onorato Measurement guide for a cyst, lesion or skin disorder
CA3136814A1 (en) * 2019-04-16 2020-10-22 Clearside Biomedical, Inc. Injectable triamcinolone formulations
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
CN114010593A (zh) * 2021-11-23 2022-02-08 莱默(北京)药业科技有限公司 一种曲安奈德混悬注射液及制备方法
CN115969784B (zh) * 2022-12-26 2025-10-21 昆明积大制药股份有限公司 曲安奈德注射液的制备方法
WO2025114562A1 (en) * 2023-11-30 2025-06-05 Institut National de la Santé et de la Recherche Médicale Intravitreal spironolactone suspension

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
US5770589A (en) 1993-07-27 1998-06-23 The University Of Sydney Treatment of macular degeneration
WO1996020712A1 (en) 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
CA2336703A1 (en) 1998-07-10 2000-01-20 The University Of Sydney Prophylactic treatments of neovascularisation in macular degeneration
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AUPQ496500A0 (en) 2000-01-06 2000-02-03 University Of Sydney, The Kit
US6395294B1 (en) 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
US6656505B2 (en) * 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
WO2002015878A1 (fr) * 2000-08-25 2002-02-28 Senju Pharmaceutical Co., Ltd. Preparations en suspension aqueuse
HRP20040102A2 (en) * 2001-07-09 2004-10-31 Combinatorx Combinations for the treatment of inflammatory disorders
US20030129242A1 (en) 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
WO2004073607A2 (en) * 2003-02-20 2004-09-02 Alcon, Inc. Use of steroids to treat ocular disorders
US20040186084A1 (en) 2003-03-21 2004-09-23 Akorn, Inc. Triamcinolone formulations and methods for their preparation and use
RU2006113593A (ru) * 2003-09-23 2006-08-27 Алькон, Инк. (Ch) Препаративные формы триамцинолона ацетонида и анекортава ацетата для инъекций
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050169992A1 (en) * 2003-12-23 2005-08-04 Frank Jao Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20070225727A1 (en) 2004-05-31 2007-09-27 Keiichi Matsuhisa Transparent Tissue-Visualizng Preparation
US8246949B2 (en) 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
AU2005306309A1 (en) 2004-11-17 2006-05-26 Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Steroid formulation and methods of treatment using same
EP1867334A4 (en) 2005-02-18 2009-07-15 Santen Pharmaceutical Co Ltd METHOD FOR RELIEVING OR AVOIDING A SECONDARY EFFECT OF A STEROID COMPOUND
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
ITRM20050547A1 (it) 2005-11-04 2007-05-05 Sooft Italia S R L Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico.
JP5581227B2 (ja) * 2008-03-11 2014-08-27 アルコン リサーチ， リミテッド 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤

Also Published As

Publication number Publication date
TWI468165B (zh) 2015-01-11
MX2010009974A (es) 2010-09-30
US8128960B2 (en) 2012-03-06
US20120116216A1 (en) 2012-05-10
EP2262506B1 (en) 2014-05-07
CL2009000573A1 (es) 2010-01-04
ES2471122T3 (es) 2014-06-25
TW200940071A (en) 2009-10-01
RU2481842C2 (ru) 2013-05-20
CA2717605C (en) 2012-05-15
KR20100127267A (ko) 2010-12-03
US20120115829A1 (en) 2012-05-10
SI2262506T1 (sl) 2014-07-31
CN101959519B (zh) 2013-03-20
BRPI0909630B1 (pt) 2019-03-26
JP2011513492A (ja) 2011-04-28
AR070824A1 (es) 2010-05-05
CN101959519A (zh) 2011-01-26
DK2262506T3 (da) 2014-06-10
BRPI0909630A2 (pt) 2015-09-22
EP2262506A1 (en) 2010-12-22
RU2010141542A (ru) 2012-04-20
JP5581227B2 (ja) 2014-08-27
AU2009223649A1 (en) 2009-09-17
KR101555293B1 (ko) 2015-10-06
US8211880B2 (en) 2012-07-03
HK1146464A1 (en) 2011-06-10
ZA201005839B (en) 2011-10-26
AU2009223649B2 (en) 2013-08-29
CA2717605A1 (en) 2009-09-17
BRPI0909630B8 (pt) 2021-05-25
WO2009114521A1 (en) 2009-09-17
US20090233890A1 (en) 2009-09-17
PL2262506T3 (pl) 2014-09-30
PT2262506E (pt) 2014-06-24

Similar Documents

Publication Publication Date Title
UY31699A1 (es) Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea
SV2008003071A (es) Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40
ES2530170T3 (es) Material de filtro transparente
DE602006008625D1 (de) Polymermicellen für die arzneistoffzufuhr
UY31198A1 (es) Amidas de ácidos benzoicos triazinil sustituidos, composiciones farmacéticas conteniéndolos y aplicaciones.
ATE522593T1 (de) Textilpflegemittel mit formaldehydfängern
UY37098A (es) Moduladores de ror-gamma
MX2014008457A (es) Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz.
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
AR059330A1 (es) Composiciones acondicionadoras del cabello
EA201891754A1 (ru) Композиции гиалуроновой кислоты, включающие мепивакаин
AR072601A1 (es) Particulas de entrega
AR060739A1 (es) Composiciones orales que comprenden polimeros de siloxano
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
GT200600475A (es) Derivados de pirazina
CL2022003194A1 (es) Composiciones farmacéuticas inyectables y usos de las mismas
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
MX2016004885A (es) Composicion de polimero funcionalizado.
UY28247A1 (es) Compuestos de benzopirano para uso en el tratamiento y la prevención de afecciones relacionadas con la inflamación.
AR054937A1 (es) Goma de mascar biodegradable
MX2010003914A (es) Nuevas composiciones a base de taxoides.
ECSP10010153A (es) Composiciones farmacéuticas que contienen antagonistas de bradiquinina y ácido hialurónico y sus usos
BR112015002416A2 (pt) agente de ligação com estabilidade biodegradável para um detergente sólido
BR112016022628A2 (pt) Composição, processo para produzir um copolímero em bloco, e, copolímero em bloco
CO6551718A2 (es) Formas de critales de componente de sulfonilurea y el método para producirlos

Legal Events

Date Code Title Description
105 Application deemed to be withdrawn (no grant fee paid)

Effective date: 20201218